Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients

Author： Wang Jenny T Hoffman Benson Blumenthal James A

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.1, 2011-01, pp. : 85-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvastatin Reduces Cardiac Mortality in Patients with Coronary Heart Disease

By Ballantyne Christie Riegger Günter Moore Nicholas Saia Francesco Serruys Patrick

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H. Kennedy F.P. Garratt K.N.

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease

By Cooke Glen E Goldschmidt-Clermont Pascal J

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 815-826

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

By Rosen Virginia M.

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 47-60

Adis International

Access to resources Recommend Favorite